| 1. Modeling |
(Laporta et al., 2013; Sepúlveda et al., 2015; Castellanos et al., 2015; Pizzitutti et al., 2015) |
1. Transfusion-transmitted malaria |
(Alho et al., 2017) |
| 2. Plasmodium vivax drugs |
(Daher et al., 2018) |
2. Plasmodium vivax resistance to chloroquine |
(Daniel-Ribeiro et al., 2008; Silva-Nunes et al., 2012; Ferreira and Castro, 2016; Siqueira et al., 2016; Recht et al., 2017; Daher et al., 2018) |
| 3. Plasmodium vivax vaccine |
(Cabrera-Mora et al., 2015) |
3. Plasmodium vivax relapse |
(Barbosa et al., 2014; Vitor-Silva et al., 2016; Siqueira et al., 2016; Daher et al., 2018) |
| 4. Ivermectin vector control |
(Chaccour et al., 2015) |
4. Asymptomatic infections |
(Daniel-Ribeiro et al., 2008; Chuquiyauri et al., 2012; Silva-Nunes et al., 2012; Barbosa et al., 2014; Ferreira and Castro, 2016; Fontoura et al., 2016; Siqueira et al., 2016; Recht et al., 2017) |
| 5. Genomic analysis and molecular tools |
(Pacheco et al., 2015; Pearson et al., 2016) |
5. Variant immunological responses |
(Costa et al., 2017) |
| 6. Hotspot identification |
(Rosas-Aguirre et al., 2015; Alencar et al., 2017) |
6. Malaria in pregnancy |
(Ferreira and Castro, 2016; Bótto-Menezes et al., 2016; Bardají et al., 2017; Recht et al., 2017) |
| 7. Decreasing Plasmodium falciparum
|
(Oliveira-Ferreira et al., 2010; van Eer et al., 2018) |
7. Bromeliad-malaria |
(Lorenz et al., 2015; Ferreira and Castro, 2016; Alencar et al., 2017) |
| 8. Decreasing severe cases |
(Oliveira-Ferreira et al., 2010) |
8. Submicroscopic infections |
(Barbosa et al., 2014; Ferreira and Castro, 2016; Recht et al., 2017) |
| 9. Naturally acquired immunity vaccine candidate |
(Daniel-Ribeiro et al., 2008) |
9. Evolution of Plasmodium falciparum resistance |
(Ferreira and Castro, 2016; Recht et al., 2017) |
| 10. International Centers of Excellence for Malaria Research |
(Arevalo-Herrera et al., 2012; Pacheco et al., 2015) |
10. Vector control |
(Tauil, 2011; Ferreira and Castro, 2016; Recht et al., 2017) |
| 11. Experimental assays for antimalarial drags |
(Pedroni et al., 2006) |
11. Detection of new foci of infection |
(Chuquiyauri et al., 2012; Ferreira and Castro, 2016) |
| 12. Housing interventions |
(Leandro-Reguillo et al., 2015) |
12. Environmental changes |
(Ferreira and Castro, 2016; Siqueira et al., 2016) |
|
|
13. Integrate surveillance |
(Ferreira and Castro, 2016; Vitor-Silva et al., 2016) |
|
|
14. G6PDd issue |
(Monteiro et al., 2014a, 2014b; Recht et al., 2017) |
|
|
15. Reservoir-monkeys |
(Araújo et al., 2013; Brasil et al., 2017; Figueiredo et al., 2017; Alvarenga et al., 2017) |
|
|
16. Gold mining |
(Silva-Nunes et al., 2012; Recht et al., 2017) |
|
|
17. Country border malaria |
(Chuquiyauri et al., 2012; Recht et al., 2017) |
|
|
18. Urban malaria |
(Recht et al., 2017) |
|
|
19. Complicated Plasmodium vivax malaria |
(Daniel-Ribeiro et al., 2008; Oliveira-Ferreira et al., 2010; Lacerda et al., 2012) |
|
|
20. Socioeconomic aspects |
(Siqueira et al., 2016) |
|
|
21. Chloroquine-induced pruritus |
(Ballut et al., 2013) |
|
|
22. Plasmodium vivax high genetic diversity |
(Fontoura et al., 2016) |
|
|
23. Human mobility |
(Tauil, 2011) |
|
|
24. Indigenous malaria |
(Leandro-Reguillo et al., 2015) |
